Fabrizio Michelassi: Difference between revisions
Rejecting submission: e - Topic is contrary to the purpose of Wikipedia (AFCH 0.9.1) |
→Career: removed content in the career section to not put so much emphasis on the progress of the Department and the medical school and to ultimately adhere to the guidelines/purpose of Wikipedia. |
||
| Line 28: | Line 28: | ||
During his career, Dr. Michelassi contributed new insight in the surgical treatment of [[Pancreatic cancer|pancreatic]]<ref>{{Cite journal|last=Pedrazzoli|first=S|last2=DiCarlo|first2=V|last3=Dionigi|first3=R|last4=Mosca|first4=F|last5=Pederzoli|first5=P|last6=Pasquali|first6=C|last7=Kloppel|first7=G|last8=Dhaene|first8=K|last9=Michelassi|first9=F|date=1998|title=Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma in the head of the pancreas: a multicenter, prospective, randomized study.|url=|journal=Ann Surg|volume=228|issue=4|pages=508-517|via=}}</ref> and [[Colorectal cancer|colorectal cancers]]<ref>{{Cite journal|last=Michelassi|first=F|last2=Block|first2=GE|last3=Vannucci|first3=L|last4=Montag|first4=A|last5=Chappell|first5=R|date=1988|title=5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma.|url=|journal=Ann Surg|volume=208|issue=3|pages=379-389|via=}}</ref>, [[ulcerative colitis]]<ref>{{Cite journal|last=Michelassi|first=F|last2=Lee|first2=J|last3=Rubin|first3=M|last4=Fichera|first4=A|last5=Kasza|first5=K|last6=Karrison|first6=T|last7=Hurst|first7=RD|date=2003|title=Long term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study.|url=|journal=Ann Surg|volume=238|pages=433-445|via=}}</ref> and [[Crohn's disease|Crohn’s disease]]<ref>{{Cite journal|last=Michelassi|first=F|last2=Balestracci|first2=T|last3=Chappell|first3=R|last4=Block|first4=GE|date=1991|title=Primary and recurrent Crohn's disease: Experience with 1,379 patients.|url=|journal=Ann Surg|volume=214|issue=3|pages=230-240|via=}}</ref> through research and participation to multiple clinical trials. He pioneered the development of important new techniques that ensure better outcomes and improved quality of life for patients with rectal cancer and ulcerative colitis. Most notably, his experience and expertise in treating Crohn’s disease led him to develop a novel bowel-sparing procedure, now known as the “[[Michelassi Strictureplasty]]”<ref>{{Cite journal|last=Michelassi|first=F|date=1996|title=Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures.|url=|journal=Dis Colon Rectum|volume=39|issue=3|pages=345-349|via=}}</ref>, designed to avoid sacrificing large amounts of bowel at the time of surgery.<ref>{{Cite journal|last=Michelassi|first=F|last2=Mege|first2=D|last3=Rubin|first3=M|last4=Hurst|first4=R|date=August 2018|title=Long-term results of the side-to-side isoperistaltic strictureplasty in Crohn disease: 25-year follow up and outcomes.|url=|journal=Ann Surg (E-Pub)|volume=|pages=|via=}}</ref> |
During his career, Dr. Michelassi contributed new insight in the surgical treatment of [[Pancreatic cancer|pancreatic]]<ref>{{Cite journal|last=Pedrazzoli|first=S|last2=DiCarlo|first2=V|last3=Dionigi|first3=R|last4=Mosca|first4=F|last5=Pederzoli|first5=P|last6=Pasquali|first6=C|last7=Kloppel|first7=G|last8=Dhaene|first8=K|last9=Michelassi|first9=F|date=1998|title=Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma in the head of the pancreas: a multicenter, prospective, randomized study.|url=|journal=Ann Surg|volume=228|issue=4|pages=508-517|via=}}</ref> and [[Colorectal cancer|colorectal cancers]]<ref>{{Cite journal|last=Michelassi|first=F|last2=Block|first2=GE|last3=Vannucci|first3=L|last4=Montag|first4=A|last5=Chappell|first5=R|date=1988|title=5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma.|url=|journal=Ann Surg|volume=208|issue=3|pages=379-389|via=}}</ref>, [[ulcerative colitis]]<ref>{{Cite journal|last=Michelassi|first=F|last2=Lee|first2=J|last3=Rubin|first3=M|last4=Fichera|first4=A|last5=Kasza|first5=K|last6=Karrison|first6=T|last7=Hurst|first7=RD|date=2003|title=Long term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study.|url=|journal=Ann Surg|volume=238|pages=433-445|via=}}</ref> and [[Crohn's disease|Crohn’s disease]]<ref>{{Cite journal|last=Michelassi|first=F|last2=Balestracci|first2=T|last3=Chappell|first3=R|last4=Block|first4=GE|date=1991|title=Primary and recurrent Crohn's disease: Experience with 1,379 patients.|url=|journal=Ann Surg|volume=214|issue=3|pages=230-240|via=}}</ref> through research and participation to multiple clinical trials. He pioneered the development of important new techniques that ensure better outcomes and improved quality of life for patients with rectal cancer and ulcerative colitis. Most notably, his experience and expertise in treating Crohn’s disease led him to develop a novel bowel-sparing procedure, now known as the “[[Michelassi Strictureplasty]]”<ref>{{Cite journal|last=Michelassi|first=F|date=1996|title=Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures.|url=|journal=Dis Colon Rectum|volume=39|issue=3|pages=345-349|via=}}</ref>, designed to avoid sacrificing large amounts of bowel at the time of surgery.<ref>{{Cite journal|last=Michelassi|first=F|last2=Mege|first2=D|last3=Rubin|first3=M|last4=Hurst|first4=R|date=August 2018|title=Long-term results of the side-to-side isoperistaltic strictureplasty in Crohn disease: 25-year follow up and outcomes.|url=|journal=Ann Surg (E-Pub)|volume=|pages=|via=}}</ref> |
||
'''Influence on the Department of Surgery at New York-Presbyterian/Weill Cornell Medical Center''' |
|||
Under the leadership of Dr. Michelassi, the Department of Surgery (DoS) at New York-Presbyterian/Weill Cornell Medical Center (NYP-WCMC) and Weill Cornell Medicine has enjoyed a trajectory of continuous, robust growth.<ref>{{Cite book|title=Department of Surgery, NewYork-Presbyterian Hospital/Weill Cornell Medical Center: A Time of Transformation|last=|first=|publisher=Monroe Litho, Inc.|year=2011|isbn=|location=|pages=}}</ref> Over the past 14 years, the faculty has almost tripled to 102 full-time or part-time faculty members in addition to 123 voluntary faculty and 225 affiliated faculty, for a total of 450 faculty members. |
|||
The scope of practice covered by the DoS faculty members includes: Breast Surgery; Colon and Rectal Surgery; Endocrine Surgery; Liver Transplantation and Hepato-biliary-pancreatic Surgery; Kidney and Pancreas Transplantation; Minimally Invasive and Bariatric Surgery; Oral and Maxillo-Facial Surgery and Dentistry; Pediatric Surgery; Plastic and Reconstructive Surgery; Surgical Oncology; Trauma, Burns, Acute and Critical Care; and Vascular, Podiatry and Endovascular Surgery. Over the tenure of Dr. Michelassi, the number of clinical faculty and surgical cases performed at New York-Presbyterian/Weill Cornell Medical Center has doubled. Likewise, research programs have grown to include programs in Regenerative Medicine, Pancreatic Cancer, Translational Science Research, Comparative Effectiveness Research, Education and Simulation Research, Device Research, Technology Innovation Research and Clinical Trials. The Division of Research, founded in 2009, is now comprised of over 50 investigators, including faculty, postdoctoral fellows, medical students, PhD graduate students, and technical staff. |
|||
The Department of Surgery continues to focus on inspiring medical students to consider surgery as a future profession and to train residents for academic careers. The Department of Surgery continues to offer an ACGME-accredited General Surgery residency and ACGME-accredited Vascular, Critical Care, and Colon and Rectal Surgery fellowships. The department also continues to offer a Fellowship Council accredited Advanced GI/MIS Surgery fellowship and a fully accredited Endocrine Surgery fellowship and CODA approved training programs in General Practice Residency (Dentistry) and Oral and Maxillofacial Surgery. The department also continues to provide non-ACGME fellowship training in Burn Surgery. In total, the Department of Surgery trains a complement of more than 150 trainees per year. A state-of-the art Simulation Center (SAIL) facilitates educational modules and training. |
|||
Over the course of the past decade, New York-Presbyterian has transformed itself into a hospital system. The Department of Surgery faculty now extend across four of these hospital sites: New York-Presbyterian/Weill Cornell Medical Center (NYP-WCMC), New York-Presbyterian Lower Manhattan Hospital (NYP-LMH), New York-Presbyterian Queens (NYP-Q) and New York-Presbyterian Brooklyn Methodist Hospital (NYP-BMH). Simultaneously, the collaboration with Weill Cornell Medicine helped to maintain the affiliation with [[Memorial Sloan Kettering Cancer Center]] and to forge several important new partnerships far beyond New York City with affiliations with [[Houston Methodist Hospital|Houston Methodist]] in Texas, [[Weill Cornell Medical College in Qatar|Weill Cornell Medicine-Qatar]] in Doha, Qatar and Weill Bugando in Mwanza, Tanzania. With these new affiliations, the department’s medical students, residents and faculty participated in training, clinical service and research activities at other national and international sites. |
|||
== '''Awards, honors and professional activities''' == |
== '''Awards, honors and professional activities''' == |
||
Revision as of 13:32, 22 July 2019
 | This article, Fabrizio Michelassi, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Comment: Michaelassi is probably notable under our guideline WP:PROF, but this is not a NPOV encyclopedia article, but rather a press release or advertisement praising him and his college. The emphasis on the progress of the department and the medical school makes it clear that this was written by a promotional purpose, quite possibly by an individual of the staff employed for the purpose of doing public relations. Please see our policy , WP:COI amd WP:PAID. The provisions there for disclosure are not optional. It is quite rare for a press agent to write a satisfactory article, because the nature of their work is different from the nature of the work done by volunteers writing WP articles. Please wait until someone unconnectedf with the college write an article. DGG ( talk ) 09:24, 20 July 2019 (UTC)
Fabrizio Michelassi, M.D., F.A.C.S. is the Chairman of the Department of Surgery at Weill Cornell Medicine and Surgeon-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center, a position he has held since 2004.
Early Life
Dr. Fabrizio Michelassi was born in Pisa, Italy. [1] Coming from a family with a background in science and medicine, Dr. Michelassi was exposed to this world at a very young age. His father was a professor of physics, both of his uncles were radiologists and his maternal grandfather was a general practitioner, who would play a major role in Dr. Michelassi’s decision to pursue a career in Medicine.[1]
Education
Dr. Michelassi started medical school at 19 and was immediately attracted by surgery. During medical school Dr. Michelassi spent several months at the Massachusetts General Hospital (MGH) in Boston as a visiting student. This experience made him appreciate the value of the North American residency training and mature the decision to come to the United States for a general surgery residency.[1]
Upon graduating from the University of Pisa School of Medicine summa cum laude. Dr. Michelassi matched in general surgery at New York University in New York. At that time, the chairman was Dr. Frank Spencer, a cardiac surgeon, later president of the American Surgical Association and president of the American College of Surgeons. Other surgeons on the faculty included Dr. John Ranson (of the “Ranson criteria” for pancreatitis), Dr. Arthur Localio, a master GI surgeon and Dr. Anthony Imparato, a master vascular surgeon. All of them had great impact on Dr. Fabrizio Michelassi.[1]
During the senior years, Dr. Michelassi took two years off for research and went back to the MGH to the laboratory oenes and prostaglandins had been just synthesized which allowed Dr. Michelassi to study their effects on the myocardium.[2]
Career
After residency, Dr. Michelassi joined the University of Chicago as an assistant professor. He was recruited by Dr. David B. Skinner to work with Dr. George Block, a master GI surgeon. They both had a tremendous impact on Dr. Michelassi, specifically Dr. Skinner’s mentoring of junior faculty was instrumental in Dr. Michelassi’s academic progression. Although Dr. Skinner left the University of Chicago, only three years after Dr. Michelassi’s recruitment, to assume the position of President of The New York Hospital, he continued to mentor Dr. Michelassi until he prematurely passed away in January 2003.
Dr. Michelassi stayed at the University of Chicago for twenty years during which time he became the Thomas D. Jones Professor of Surgery, Chief of the Section of General Surgery and vice-chair of the Department of Surgery. In 2004, Dr. Michelassi was recruited by NewYork-Presbyterian/Weill Cornell Medical Center in New York City to become the Lewis Atterbury Stimson Professor, Chairman of the Department of Surgery and Surgeon-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center.
During his career, Dr. Michelassi contributed new insight in the surgical treatment of pancreatic[3] and colorectal cancers[4], ulcerative colitis[5] and Crohn’s disease[6] through research and participation to multiple clinical trials. He pioneered the development of important new techniques that ensure better outcomes and improved quality of life for patients with rectal cancer and ulcerative colitis. Most notably, his experience and expertise in treating Crohn’s disease led him to develop a novel bowel-sparing procedure, now known as the “Michelassi Strictureplasty”[7], designed to avoid sacrificing large amounts of bowel at the time of surgery.[8]
Awards, honors and professional activities
A recognized leader in the gastrointestinal surgical field, Dr. Fabrizio Michelassi has obtained membership in more than 50 professional societies and has been elected to leadership positions in many of them, serving as president in seven: The Society for the Surgery of the Alimentary Tract, the Society of Surgical Oncology, the Society of Surgical Chairs, the Western Surgical Society, the Central Surgical Association, the Illinois Surgical Society and the New York Surgical Society. Dr. Michelassi has been awarded Honorary Membership in four professional societies: the Sociedad de Coloproctologia del Nordesta (Argentina), the Societa Italiana di Chirurgia, the European Surgical Association and the Society of Black Academic Surgeons. Dr. Michelassi has served as Vice-President of the U.S. Chapter of the James IV Association of Surgeons, Inc., as Vice-Chair of the Advisory Council for General Surgery and as Chair of the Executive Committee of the Board of Governors of the American College of Surgeons; in 2016, he started his first term as Regent of the American College of Surgeons. Dr. Michelassi served as Director of the American Board of Surgery (2006 to 2012), Chair of the Surgical Oncology Advisory Council (2009 to 2011), inaugural Surgical Oncology Board Chair (2011 to 2012) and Senior Director (2012 to 2017).[1]
During his professional life, Dr. Fabrizio Michelassi earned numerous awards for his innovative contributions to advancing the treatment of digestive diseases. In 2009, in recognition of his many lifetime achievements, Dr. Michelassi was honored as an Official of the Order of Merit of the Republic of Italy with the rank of Commendatore, awarded by the President of the Republic of Italy to Italian citizens of particular merit. In 2010, he received the prestigious “Campano d’Oro” medal from the University of Pisa, the highest honor that can be accorded to a University of Pisa alumnus. In 2012, he received the “Grand Award of Merit,” the most notable award of the American Society of the Italian Legions of Merit, in recognition of his accomplishments, dedication and leadership that have improved the lives of numerous Americans, Italians and Italian Americans. Previous recipients of the Grand Award of Merit include H.E. Giorgio Napolitano, President of the Republic of Italy, George W. Bush, former President of the United States, Antonino Scalia, previous Supreme Court judge, and United States Congresswoman Nancy Pelosi. In 2014, Dr. Fabrizio Michelassi was awarded the National Physician of the Year Award for Clinical Excellence from Castle Connolly, in recognition of his pioneering contributions to the field of gastrointestinal surgery. In 2017, Dr. Michelassi was the recipient of the Society of Surgical Oncology Distinguished Service Award for outstanding contributions to surgical oncology through service to SSO, research, clinical care or health policy. In the same year, in acknowledgment of Dr. Michelassi’s dedication to service at NewYork-Presbyterian and Weill Cornell Medicine, he was awarded the 37th Annual Maurice R. Greenberg Distinguished Service Award.[1] Last, but not least, he was honored as the Outstanding Teacher of the Year by residents on three separate occasions in recognition of his abiding, life-long interest in educating and training the next cadre of academic surgeons. As further evidence of his dedication to the field of Surgery, the Fabrizio Michelassi, M.D. Chief Surgical Resident Award was established in 2007. This award is presented annually during graduation to the resident who most displays “humane, responsive, respectful and personalized patient care”, as exemplified by Dr. Michelassi.[1]
References
- ^ a b c d e f g [1. https://surgery.weill.cornell.edu/120-year-anniversary-department-surgery 1. https://surgery.weill.cornell.edu/120-year-anniversary-department-surgery].
{{cite web}}: Check|url=value (help); Cite has empty unknown parameter:|dead-url=(help); Missing or empty|title=(help); horizontal tab character in|url=at position 3 (help) - ^ Michelassi, F; Landa, L; Hill, RD; Lowenstein, E; Watkins, WD; Petkau, AJ; Zapol, WM (1982). "Leukotriene D4: A potent coronary artery vasoconstrictor associated with impaired ventricular contraction". Science. 217: 841–843.
- ^ Pedrazzoli, S; DiCarlo, V; Dionigi, R; Mosca, F; Pederzoli, P; Pasquali, C; Kloppel, G; Dhaene, K; Michelassi, F (1998). "Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma in the head of the pancreas: a multicenter, prospective, randomized study". Ann Surg. 228 (4): 508–517.
- ^ Michelassi, F; Block, GE; Vannucci, L; Montag, A; Chappell, R (1988). "5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma". Ann Surg. 208 (3): 379–389.
- ^ Michelassi, F; Lee, J; Rubin, M; Fichera, A; Kasza, K; Karrison, T; Hurst, RD (2003). "Long term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study". Ann Surg. 238: 433–445.
- ^ Michelassi, F; Balestracci, T; Chappell, R; Block, GE (1991). "Primary and recurrent Crohn's disease: Experience with 1,379 patients". Ann Surg. 214 (3): 230–240.
- ^ Michelassi, F (1996). "Side-to-side isoperistaltic strictureplasty for multiple Crohn's strictures". Dis Colon Rectum. 39 (3): 345–349.
- ^ Michelassi, F; Mege, D; Rubin, M; Hurst, R (August 2018). "Long-term results of the side-to-side isoperistaltic strictureplasty in Crohn disease: 25-year follow up and outcomes". Ann Surg (E-Pub).
External Links
1. https://surgery.weill.cornell.edu